
Codex Genetics is a precision medicine company that provides end-to-end solutions using AI-powered analytics for disease management. Their CoGenesis® genetic testing technology and bioinformatics platform accelerate diagnostics, aid in treatment planning, and improve medical decision-making for patients with genetic diseases. They offer a range of genetic tests including Hereditary Cancer Test, Neurodegenerative Disease Test, Drug Response Test, Congenital Cardiovascular Disease Test, and Metagenomics. Their platform leverages machine learning and big data analytics, powered by the Illumina NextSeq 2000 System, to provide actionable clinical insights. Codex Genetics emphasizes high standards of accuracy, having passed GenQA/UK NEQAS external quality assurance and achieved ISO27001 certification for information security.

Codex Genetics is a precision medicine company that provides end-to-end solutions using AI-powered analytics for disease management. Their CoGenesis® genetic testing technology and bioinformatics platform accelerate diagnostics, aid in treatment planning, and improve medical decision-making for patients with genetic diseases. They offer a range of genetic tests including Hereditary Cancer Test, Neurodegenerative Disease Test, Drug Response Test, Congenital Cardiovascular Disease Test, and Metagenomics. Their platform leverages machine learning and big data analytics, powered by the Illumina NextSeq 2000 System, to provide actionable clinical insights. Codex Genetics emphasizes high standards of accuracy, having passed GenQA/UK NEQAS external quality assurance and achieved ISO27001 certification for information security.